Related Experiment Video
Updated: May 5, 2026

06:54
Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions
Published on: June 21, 2019
5.4K
Obesity in the new millennium.
1The Rockefeller University, New York, New York 10021-6399, USA.
Nature
|April 15, 2000
Summary
Obesity is a growing global health issue. Research is identifying key genes and the hormone leptin involved in body weight regulation, offering hope for new obesity treatments.
Area of Science:
- Endocrinology
- Genetics
- Public Health
Background:
- Obesity rates have surged globally, posing significant public health challenges.
- Obesity is linked to severe health issues like hypertension and heart disease, alongside social stigma.
- Understanding the body weight regulation system is crucial for addressing the obesity epidemic.
Purpose of the Study:
- To summarize recent advances in identifying the components of the body weight homeostatic system.
- To highlight the role of key molecules, such as the hormone leptin, in regulating appetite and body weight.
- To explore the potential for novel therapeutic strategies based on molecular insights into obesity.
Main Methods:
- Review of recent scientific literature on obesity and weight regulation.
- Identification of key genes and molecular pathways implicated in obesity.
- Analysis of the physiological role of hormones like leptin in energy balance.
Main Results:
- Significant progress has been made in identifying genes contributing to obesity in animals and humans.
- The hormone leptin has been identified as a critical regulator of food intake and body weight, acting on the brain.
- Further research is uncovering additional molecular components of the weight-regulating homeostatic system.
Conclusions:
- Continued identification of molecules in the homeostatic system will deepen our understanding of obesity's molecular basis.
- Advances in molecular biology offer promising avenues for developing new treatments for obesity.
- Targeting specific components of the weight regulation system could lead to effective obesity management strategies.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Binge Eating Disorders
828
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
828
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17

